Pharmaceutical Glass Packaging Market Growth, Demand and Challenges of the Key Industry Players 2024-32


MARKETRESEARCH

Uploaded on Apr 30, 2024

According to the latest research report by IMARC Group, The global pharmaceutical glass packaging market size reached US$ 9.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. More Info:- https://www.imarcgroup.com/pharmaceutical-glass-packaging-market

Comments

                     

Pharmaceutical Glass Packaging Market Growth, Demand and Challenges of the Key Industry Players 2024-32

Global Pharmaceutical Glass Packaging Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . Accord ing t o t he la t es t repor t by IMARC Group, t i t l ed "Pharmaceut ica l G lass Packag ing Market : G lobal I ndust ry T rends , Share , S ize , Growth , Oppor tun i ty and Forecast 2024-2032, " t he g loba l pharmaceut i ca l g lass packag ing marke t s i ze reached US$ 9 .4 B i l l i on i n 2023. Report Glass i s w ide ly u t i l i zed as a p r imary packag ing ma te r ia l f o r var ious pharmaceu t i ca l p roduc ts . I t ex t ends the she l f l i f e , p reserves vo la t i l e ingred ien ts , m in im izes t he chances o f acc iden ta l b reakage , and p ro tec ts the pharm aceu t i ca l Highlight and produc t s aga ins t damage caused by t he ex te rna l env i ronmen t such as a i r , mo i s t u re , and l i gh t . Description I n add i t i on , co lo red g lass , such as amber and red-co lo red g lass , p ro tec ts the con ten t s f r om u l t rav io le t (UV) rays and spec i f i c wave leng ths . Moreover , g lass packag ing f inds ex tens ive app l i ca t ions in t he pharmaceut i ca l i ndus t ry as i t p rese rves t em pera tu re -sens i t i ve d rugs such as vacc ines and i nsu l in . Request fo r a PDF sample o f th is repor t : ht tps : / / www. imarcgroup .com/pharmaceut i ca l -g l ass -packag ing-marke t / reques t samp le Report Description G lo b a l P h a r m a c e u t i c a l G la s s P a c k a g i n g M a r k e t T r e n d s : T h e m a r k e t i s p r i m a r i l y d r i v e n b y t h e e x p a n d i n g p h a r m a c e u t i c a l i n d u s t r y . N o w a d a y s , g l a s s p a c k a g i n g i s u s e d t o p r o te c t p h a r m a c e u t i c a l c o n t e n t s a g a i n s t p h y s i c a l d a m a g e , h y d r o l y s i s , a n d o x i d a t i o n , p r e v e n t t h e i r b i o l o g i c a l c o n t a m i n a t i o n a n d r e d u c e t h e d r u g ’ s s u s c e p t i b i l i t y t o d e g r a d a t i o n . I n a d d i t i o n , t h e i n t r o d u c t i o n o f i n n o v a t i v e p r o d u c t v a r i a n t s b y l e a d i n g m a n u fa c t u r e r s , s u c h a s t h i n a n d l i g h tw e i g h t g l a s s b o t t l e s t o m i n i m i z e t h e o v e r a l l c o n s u m p t i o n o f e n e r g y a n d r a w m a t e r i a l s , r e p r e s e n t s a n o th e r m a j o r g r o w t h - i n d u c i n g f a c t o r . B e s i d e s t h i s , g o v e r n i n g a u t h o r i t i e s o f n u m e r o u s c o u n t r i e s a r e t a k i n g s e v e r a l f a v o r a b l e i n i t i a t i v e s t o e n c o u r a g e t h e u s a g e o f r e c y c l e d g l a s s t o r e d u c e t h e c a r b o n f o o tp r i n t . T h i s , c o u p l e d w i t h t h e w i d e s p r e a d p r e v a l e n c e o f c h r o n i c d i s e a s e s l i k e d i a b e t e s a n d o b e s i t y a n d t h e r i s i n g h e a l t h c a r e c o n s c i o u s n e s s a m o n g t h e m a s s e s , i s c o n t r i b u t i n g t o t h e ma r k e t g r o w th . F u r t h e r m o r e , t h e g r o w i n g a w a r e n e s s r e g a r d i n g t h e a d v e r s e e f f e c t s o f p l a s t i c p a c k a g i n g , o n g o i n g r e s e a r c h a n d d e v e l o p m e n t ( R & D ) a c t i v i t i e s , a n d t h e e m e r g i n g d e m a n d f o r p a t i e n t - o r i e n t e d m e d i c i n e s s u c h a s b i o l o g i c s i s c r e a t i n g a f a v o r a b l e m a r k e t o u t l o o k a c r o s s t h e g l o b e . L o o k in g f o r w a r d , IM A R C G r o u p e x p e c t s t h e m a r k e t v a l u e t o r e a c h U S $ 1 6 .4 B i l l i o n b y 2 0 3 2 , e x h ib i t in g a C A G R o f 6 .2 % d u r in g t h e f o r e c a s t p e r i o d ( 2 0 2 4 - 2 0 3 2 ) . V ie w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / p h a r m a c e u t ic a l - g l a s s - p a c k a g i n g - m a r k e t Breakup by Product: • Bottles • Vials • Ampoules • Cartridges and Syringes • Others   Report Breakup by Drug Type: Segmentation • Generic • Branded • Biologic Breakup by Application: • Oral • Injectable • Nasal • Others Breakup by Region: • North America • Asia-Pacifi c Report • Europe Segmentation • Latin America • Middle East and Afr ica • Ardagh Group S.A • Beatson Clark • Bormiol i Pharma S.p.A. • Corning Incorporated Competitive • Gerresheimer AG Landscape • Nipro Corporat ion • Piramal Enterprises Ltd. with Key • Schott AG Players • SGD Pharma • Shandong Pharmaceutical Glass Co. Ltd. • Sisecam (Türkiye Is Bankasi A.S.) • Stölz le-Oberglas GmBH • West Pharmaceutical Services Inc. What was the size of the global pharmaceutical glass packaging market in 2023? What is the expected growth rate of the global pharmaceutical glass packaging market during 2024- 2032? What are the key factors driving the global Key pharmaceutical glass packaging market? Questions What has been the impact of COVID-19 on the global pharmaceutical glass packaging market? Answered in What is the breakup of the global pharmaceutical glass packaging market based on the product? the Report What is the breakup of the global pharmaceutical glass packaging market based on the drug type? What are the key regions in the global pharmaceutical glass packaging market? Who are the key players/companies in the global pharmaceutical glass packaging market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l P h a r m a c e u t i c a l G l a s s P a c k a g i n g M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y P r o d u c t 6 . 1 B o t t l e s 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 V i a l s 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 A m p o u l e s 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 C a r t r i d g e s a n d S y r i n g e s 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 6 . 5 O t h e r s 6 . 5 . 1 M a r k e t T r e n d s 6 . 5 . 2 M a r k e t F o r e c a s t 7 M a r k e t B r e a k u p b y D r u g T y p e 7 . 1 G e n e r i c 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 B r a n d e d Table of 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t 7 . 3 B i o l o g i c 7 . 3 . 1 M a r k e t T r e n d s Contents 7 . 3 . 2 M a r k e t F o r e c a s t8 M a r k e t B r e a k u p b y A p p l i c a t i o n 8 . 1 O r a l 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t 8 . 2 I n j e c t a b l e 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t 8 . 3 N a s a l 8 . 3 . 1 M a r k e t T r e n d s 8 . 3 . 2 M a r k e t F o r e c a s t 8 . 4 O t h e r s 8 . 4 . 1 M a r k e t T r e n d s 8 . 4 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : ht t ps : / /w ww. i ma rc gro up . c o m /p ha rm a c eut i c a l - g l a ss -pa c ka g i ng -m a rke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]